Company Filing History:
Years Active: 2016
Title: John Mecom: Innovator in Pharmaceutical Compounds
Introduction
John Mecom is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work with benzazepine compounds. His research focuses on the modulation of serotonin receptors, which are crucial in treating various mental health conditions.
Latest Patents
John Mecom holds 1 patent related to a series of compounds and pharmaceutical compositions. His patent describes the use of these compounds as therapeutic agents, specifically targeting serotonin receptor (5-HT) ligands. These compounds are designed to address diseases and disorders such as addiction, anxiety, depression, and obesity.
Career Highlights
Throughout his career, John has been associated with Abt Holding Company, where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding of serotonin receptors and their implications in various health conditions.
Collaborations
John has collaborated with notable colleagues, including Mike Robarge and John Joseph Harrington, to enhance the impact of his research and innovations in the pharmaceutical industry.
Conclusion
John Mecom's contributions to the field of pharmaceuticals through his innovative compounds and research on serotonin receptors highlight his importance as an inventor. His work continues to pave the way for advancements in therapeutic agents.